Corbus Pharmaceuticals Holdings (CRBP) EBIT Growth (3y) (2016 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) EBIT Growth (3y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | -1,580.97% |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 32.96% |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | -29.67% |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -50.81% |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | 16.35% |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 13.47% |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Corbus Pharmaceuticals Holdings | 136.49 Mn | 108.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 28.82% |
| Jun 30, 2025 | -15.78% |
| Mar 31, 2025 | -32.42% |
| Dec 31, 2024 | 29.62% |
| Sep 30, 2024 | 28.81% |
| Jun 30, 2024 | 27.97% |
| Mar 31, 2024 | 27.38% |
| Dec 31, 2023 | 21.41% |
| Sep 30, 2023 | 34.64% |
| Jun 30, 2023 | 40.12% |
| Mar 31, 2023 | 16.66% |
| Dec 31, 2022 | 26.50% |
| Sep 30, 2022 | 31.18% |
| Jun 30, 2022 | -109.82% |
| Mar 31, 2022 | 31.52% |
| Dec 31, 2021 | 17.17% |
| Sep 30, 2021 | 2.34% |
| Jun 30, 2021 | -10.45% |
| Mar 31, 2021 | -9.12% |
| Dec 31, 2020 | -24.20% |